ArriVent BioPharma, Inc.（AVBP）价格预测AVBPArriVent BioPharma, Inc.

Alphio's AVBP stock price prediction model matches the current ArriVent BioPharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.85 (-0.70%). The 1-week path is $21.18 (+0.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Arrivent Biopharma Inc is not a strong buy due to significant recent trial failures that have led to a 48% stock drop. The current price is $21, while analysts have downgraded their price targets significantly, with the lowest at $18, indicating potential downside risk. However, the stock has shown a 26.05% increase over the last 5 days, suggesting some recovery momentum. The RSI is at 69.511, indicating it is approaching overbought territory, which could lead to a pullback. Therefore, it may be prudent to hold rather than buy right now, as the risks outweigh the potential rewards in the short term.

ArriVent BioPharma, Inc. (AVBP) last closed at $21, gaining +9.38%. These facts feed the 1-day and 1-week AVBP price prediction above.